PrintFaculty Profile
CHRISTOPHER J. LONGO
Dr. Longo has 16 years of industry experience in clinical research, economic evaluation, and market access strategies for pharmaceuticals. He has published both clinical and economic research in a number of therapeutic areas including: diabetes, cancer, sepsis, and central nervous system disorders. Dr. Longo’s research interests include the economic evaluation of pharmaceuticals, the public/private mix in the financing of healthcare, and the evaluation of factors influencing patients’ financial burden for health care services.
Dr. Longo has consulted with numerous provincial and federal agencies related to economic evaluation of pharmaceuticals including: the Canadian Agency for Drugs & Technology in Health, Cancer Care Ontario, and the National Cancer Institute of Canada. Dr. Longo was the past chair of Rx&D’s (Canada’s Research-Based Pharmaceutical Companies) Health Economic Working Group from 2002-2004. Dr. Longo has also acted as an expert advisor to a number of Rx&D committees between 1997-2005. Dr. Longo has undertaken reviews for the journals Pharmacoeconomics, Medical Care Canadian Medical Association Journal, Supportive Care in Cancer, Health & Quality of Life Outcomes, and Canadian Journal of Diabetes.
Ph.D. Health Policy, Management, and Evaluation, Faculty of Medicine, University of Toronto
M.Sc. Physiology, Faculty of Medicine & Dentistry, University of Western Ontario
B.A. Economics, Faculty of Arts, York University
DeGroote School of Business
McMaster University
1280 Main Street West
Hamilton, ON, Canada
L8S4M4